Profile data is unavailable for this security.
About the company
Essity AB (publ) is a Sweden-based hygiene and health company that develops, produces, markets and sells personal care and tissue products. The Company conducts sales in about 150 countries under such brands, as TENA for incontinence products and Tork for Away-from-Home tissue, as well as under other brands, such as Bodyform, Velvet, Cushelle and Plenty. The Company’s medical brands comprise Leukoplast, Cutimed, JOBST, Delta Cast, Delta Lite and Actimove.
- Revenue in SEK (TTM)124.52bn
- Net income in SEK11.81bn
- Incorporated1988
- Employees36.01k
- LocationEssity AB (publ)Box 200STOCKHOLM 101 23SwedenSWE
- Phone+46 87885100
- Websitehttps://www.essity.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Essity AB (publ) | 124.52bn | 11.81bn | 209.91bn | 36.01k | 17.76 | 2.50 | 11.91 | 1.69 | 16.83 | 29.69 | 177.44 | 119.41 | 0.6349 | 3.72 | 5.05 | 3,457,529.00 | 5.99 | 5.07 | 8.64 | 7.49 | 34.89 | 29.41 | 9.44 | 7.08 | 0.9543 | 10.30 | 0.362 | 58.97 | 12.05 | 4.43 | 84.74 | 3.66 | -0.1627 | 6.15 |
| Galderma Group AG | 47.74bn | -157.03m | 253.43bn | 6.55k | -- | 3.00 | 83.86 | 5.31 | -0.053 | -0.053 | 16.11 | 28.48 | -- | -- | -- | 584,792.00 | -- | -- | -- | -- | 69.54 | -- | -0.3266 | -- | 0.9206 | 1.20 | 0.2786 | -- | 7.65 | -- | 40.97 | -- | -- | -- |
| Beiersdorf AG | 112.22bn | 8.55bn | 348.09bn | 22.49k | 37.20 | 3.23 | 28.34 | 3.10 | 3.26 | 3.26 | 42.71 | 37.47 | 0.738 | 2.69 | 4.45 | 441,114.80 | 5.71 | 6.38 | 8.28 | 8.95 | 58.14 | 57.23 | 7.74 | 8.60 | 1.34 | -- | 0.0622 | 25.33 | 7.36 | 5.49 | -2.52 | 0.2188 | 7.63 | 7.39 |
| Reckitt Benckiser Group Plc | 199.51bn | 21.50bn | 454.83bn | 40.00k | 21.85 | 4.11 | 16.15 | 2.28 | 2.17 | 2.17 | 20.07 | 11.54 | 0.5314 | 3.49 | 6.58 | 358,200.00 | 5.75 | 1.54 | 8.25 | 2.10 | 60.56 | 59.32 | 10.81 | 3.37 | 0.4692 | 18.66 | 0.5237 | 283.98 | 1.07 | 3.01 | -30.08 | -5.48 | 0.5433 | 2.43 |
Data as of Nov 22 2024. Currency figures normalised to Essity AB (publ)'s reporting currency: Swedish Krona SEK
29.73%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| MFS Institutional Advisors, Inc.as of 29 Dec 2023 | 35.13m | 5.47% |
| Norges Bank Investment Managementas of 29 Dec 2023 | 34.84m | 5.43% |
| Swedbank Robur Fonder ABas of 31 Oct 2024 | 27.62m | 4.30% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 21.17m | 3.30% |
| Handelsbanken Fonder ABas of 31 Oct 2024 | 21.04m | 3.28% |
| Nordea Investment Management ABas of 30 Sep 2024 | 12.38m | 1.93% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 11.31m | 1.76% |
| Carnegie Fonder ABas of 30 Sep 2024 | 9.81m | 1.53% |
| SEB Investment Management ABas of 31 Oct 2024 | 9.46m | 1.47% |
| L�nsf�rs�kringar Fondf�rvaltning ABas of 31 Oct 2024 | 8.10m | 1.26% |
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
